US 7795267
Bicyclic piperazine compound having TGR23 antagonistic activity
granted A61PA61P1/14A61P25/28
Quick answer
US patent 7795267 (Bicyclic piperazine compound having TGR23 antagonistic activity) held by Takeda Pharmaceutical Company Limited expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/14, A61P25/28, A61P3/06, A61P3/10